Pramlintide improved glycaemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin

被引：0
|
作者：
Wilhelm, K. [1 ]
Riddle, M. [2 ]
Zhang, B. [1 ]
Maier, H. [1 ]
Kolterman, O. [1 ]
机构：
[1] Amylin Pharmaceut, San Diego, CA USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1011
引用
收藏
页码：S409 / S409
页数：1
相关论文
共 50 条
  • [31] Sitagliptin Monotherapy improved glycaemic control in patients with type 2 diabetes
    Aschner, P.
    Kipnes, M.
    Lunceford, J.
    Sanchez, M.
    Mickel, C.
    Davies, M. J.
    Williams-Herman, D.
    DIABETOLOGIA, 2006, 49 : 5 - 5
  • [32] Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
    Inzucchi, S. E.
    Nauck, M. A.
    Hehnke, U.
    Woerle, H-J.
    von Eynatten, M.
    Henry, R. R.
    DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 868 - 877
  • [33] Comparison of Mealtime Pramlintide, Insulin, or a Combination of Both, When Added to Basal Insulin Treatment in Patients with Type 2 Diabetes
    Karounos, Dennis
    Pencek, Rich
    Huang, Wenying
    Miller, Stephan
    Lutz, Karen
    Porter, Lisa
    DIABETES, 2009, 58 : A32 - A32
  • [34] Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes
    Overbeek, Jetty A.
    Heintjes, Edith M.
    Huisman, Eline L.
    Tikkanen, Christian K.
    van Diermen, Arnout W.
    Penning-van Beest, Fernie J. A.
    Herings, Ron M. C.
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2093 - 2102
  • [35] Comparison of mealtime pramlintide, insulin, or a combination of both, when added to basal insulin treatment in patients with type 2 diabetes
    Karounos, D.
    Pencek, R.
    Huang, W.
    Miller, S.
    Lutz, K.
    Porter, L.
    DIABETOLOGIA, 2009, 52 : S358 - S358
  • [36] The effectiveness of a diabetes nurse clinic in treating older patients with type 2 diabetes for their glycaemic control
    Chan, Moon Fai
    Yee, Amy Shun Wah
    Leung, Elaine Lai Yee
    Day, Mary Christine
    JOURNAL OF CLINICAL NURSING, 2006, 15 (06) : 770 - 781
  • [37] Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets
    Hollander, P
    Ratner, R
    Fineman, M
    Strobel, S
    Shen, L
    Maggs, D
    Kolterman, O
    Weyer, C
    DIABETES OBESITY & METABOLISM, 2003, 5 (06): : 408 - 414
  • [38] 52 weeks pramlintide therapy as an adjunct to insulin improved metabolic control in people with type 2 diabetes
    Fineman, M
    Gottlieb, A
    Skare, S
    Kolterman, O
    DIABETOLOGIA, 2000, 43 : A204 - A204
  • [39] Basal insulin initiation on the top of metformin improves glycaemic control and safety in Chinese insulin-naive patients with type 2 diabetes
    Zhang, H.
    Zhang, P.
    Luo, Y.
    Zhu, D.
    Li, X.
    Ji, J.
    Ji, L.
    DIABETOLOGIA, 2018, 61 : S441 - S442
  • [40] Lixisenatide added to basal insulin reduces glycaemic variability in patients with type 2 diabetes mellitus
    O'Neal, D.
    Umpierrez, G.
    DiGenio, A.
    Goldenberg, R.
    Hernandez-Triana, E.
    Lin, J.
    Park, C. -Y.
    Renard, E.
    Kovatchev, B.
    DIABETOLOGIA, 2014, 57 : S342 - S342
12345